JUser: :_load: Unable to load user with ID: 37389

Immunotherapy in Genitourinary Cancers: T-cell Activation and Check Point Therapies - Sumit Subudhi

Sumit Subudhi presents exciting data on immunotherapy and check point inhibitors in genitourinary cancer.  Dr. Subudhi’s discussion includes data on patient overall survival in renal cell carcinoma and a case study showing a remarkable example of a patient being treated with ipilimumab and resulting in a durable and curative response. 


Sumit K. Subudhi, MD, PhD
Assistant Professor, Department of Genitourinary 
Medical Oncology, Division of Cancer Medicine,
The University of Texas MD Anderson Caner Center, Houston, Texas

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.